Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 USD | -5.66% | -1.64% | +27.12% |
Mar. 27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 34.76M | Capitalization | 193M |
---|---|---|---|---|---|
Net income 2024 * | -40M | Net income 2025 * | -31M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 5.56 x |
P/E ratio 2024 * |
-5.11
x | P/E ratio 2025 * |
-11.1
x | Employees | 39 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.95% |
Latest transcript on GlycoMimetics, Inc.
1 day | -5.66% | ||
1 week | -1.64% | ||
Current month | +3.81% | ||
1 month | -0.66% | ||
3 months | +20.48% | ||
6 months | +102.70% | ||
Current year | +27.12% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 59 | 18-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3 | -5.66% | 648,130 |
24-03-27 | 3.18 | +11.58% | 675,049 |
24-03-26 | 2.85 | +1.06% | 227,069 |
24-03-25 | 2.82 | -3.75% | 320,276 |
24-03-22 | 2.93 | +1.74% | 205,631 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.12% | 205M | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |